Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Misses on EPS, Stock Up 0.5%

Collegium Pharmaceutical reported a loss that was worse than expected, but the stock still saw a slight increase of 0.5% in reaction. This may indicate that investors are looking beyond the immediate earnings results, possibly focusing on longer-term potential or other factors not reflected in the earnings report. The lack of guidance and management commentary leaves some uncertainty about the company's future direction.